Age-Related Diabetes — Part 5
Age-Related Diabetes — Part 5
Where Do the Two Systems Diverge?
Throughout this series, we have examined age-related diabetes through two different lenses.
Modern medicine measures:
- insulin resistance
- declining beta-cell function
- chronic inflammation
and seeks to normalize blood glucose levels.
Classical Medicine views the same condition differently.
It observes a process in which the body's Yin foundation gradually becomes depleted, internal heat increases, and the entire system of fluid regulation becomes affected. The goal is not simply to change a number, but to restore balance within that process.
The difference between these approaches is not merely methodological.
They diverge at a more fundamental level.
The Question Modern Medicine Asks
Modern medicine asks:
What is wrong?
A fasting blood glucose level of 126 mg/dL is classified as abnormal.
A level of 125 mg/dL is classified as normal.
A difference of a single unit separates patient from non-patient.
Treatment aims to move the abnormal back into the normal range.
This approach is powerful.
It is:
- measurable
- reproducible
- testable through large clinical trials
And it has unquestionably contributed to reducing the burden of diabetic complications.
Yet a structural question remains.
When blood glucose falls from 126 to 124 mg/dL, has the body's regulatory capacity truly been restored?
Or has only the number changed?
The Question Classical Medicine Asks
Classical Medicine asks a different question:
What process is unfolding within this person?
In this framework, there is no strict boundary between normal and abnormal.
Aging is not viewed as a malfunction.
It is viewed as a process.
The gradual depletion of the Yin foundation is understood as part of the natural direction of aging.
Treatment seeks to:
- slow excessive depletion
- support regulation
- restore balance
rather than simply eliminate symptoms or alter measurements.
From this perspective, an HbA1c of 6.4% does not necessarily mean treatment is complete.
If fatigue persists,
if vitality has not returned,
if the sense of depletion remains,
then the underlying process may still be ongoing.
How Do We Observe What Cannot Be Measured?
Here the central tension emerges once again.
Modern medicine places its trust in what can be measured:
- blood glucose
- HbA1c
- insulin resistance indices
These markers can be quantified and reproduced.
What cannot be measured is often treated as either nonexistent or not yet measurable.
Yet biological systems may be more complex than any single marker can capture.
Systems biologist Denis Noble argues that biological regulation emerges through interactions occurring simultaneously across multiple levels:
- genes
- cells
- organs
- entire organisms
No single level can be considered the sole source of causation (Noble, 2012).
If this is true, then evaluating the body's regulatory state through a single number may be inherently incomplete.
Viewing age-related diabetes as a blood sugar problem and viewing it as an age-related transformation of the body's regulatory systems lead to fundamentally different questions.
And different questions often lead to different treatment strategies.
It is true that the observations accumulated by Classical Medicine over centuries have not been fully validated according to modern scientific standards.
However, not yet validated is not the same as disproven.
Whether current research methodologies are sufficient to evaluate such systems remains an open question (Deaton & Cartwright, 2018).
The Two Systems Are Not Competitors
The conclusion of this series is not that one system is right and the other is wrong.
Modern medicine excels at:
- preventing complications
- stabilizing blood glucose
- reducing the risks associated with prolonged hyperglycemia
The damage caused by chronically elevated blood sugar to blood vessels and nerves is well established.
Classical Medicine asks a different set of questions.
It focuses on the processes that may persist even after blood sugar is controlled:
- fatigue
- declining vitality
- a persistent sense of depletion
- changes in overall resilience
These concerns are not necessarily captured by glucose measurements alone.
Recognizing that the two systems may be measuring different aspects of the same individual is the central proposal of this series.
Not because one perspective must replace the other,
but because acknowledging both may allow for a more complete clinical picture of aging and diabetes.
References
Deaton A, Cartwright N. (2018). Understanding and misunderstanding randomized controlled trials. Social Science & Medicine.
Noble D. (2012). A theory of biological relativity: No privileged level of causation. Interface Focus.
댓글
댓글 쓰기